|Cape Capital AG||Switzerland, Zürich, Zurich|
|Central Banking Corporation||-|
|Eight Roads Ventures India||Bangalore, India, Karnataka|
|Fujiansheng DianziXinxi Canye Guquan Touzi||China, Foochow, Fujian|
|Fullerton Financial Holdings||Central Region, Singapore, Singapore|
|Global Infrastructure Partners (GIP)||New York, New York, United States|
|Hedef Filo||Istanbul, Kagithane, Turkey|
|Ignite Farm||California, United States, Walnut Creek|
|Impact First Investments||Herzliya, Israel, Tel Aviv|
|Junhe Capital||China, Shanghai|
|Montcalm Capital||California, San Francisco, United States|
|Ningbo Angel Capital Guiding Fund||China, Ningbo, Zhejiang|
|PSS Systems||California, Mountain View, United States|
|Quality Jobs Fund (QJF)||-|
|Service Corp International||Houston, Texas, United States|
|Shenzhen Investment Holdings||China, Futian, Guangdong|
|Snowpoint Ventures||California, San Francisco, United States|
|University of Manitoba||Canada, Manitoba, Winnipeg|
|VC4A||Amsterdam, Noord-Holland, The Netherlands|
|$80M||08 Jan 2021||California, United States|
|$64M||25 Sep 2020||Capital Region of Denmark|
– DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology and other therapeutic areas, announced the completion of its $60 million Series C-1 financing.
– The financing was led by RA Capital Management and Sands Capital, with participation from new investors Janus Henderson Investors, Deep Track Capital and Logos Capital.
– Existing investors Northpond Ventures, Eventide Asset Management, Driehaus Capital Management, Soleus Capital, New Leaf Venture Partners, Osage University Partners and Asymmetry Capital Management also participated in the round.
– With the closing of this Series C-1 financing round, the Company has raised approximately $200 million to date.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.